EC Number |
Title |
Organism |
---|
1.3.1.48 | Human prostaglandin reductase 1 (PGR1) Substrate specificity, inhibitor analysis and site-directed mutagenesis |
Homo sapiens |
1.3.1.48 | Wound healing effects of new 15-hydroxyprostaglandin dehydrogenase inhibitors |
Homo sapiens |
1.3.1.48 | 15-Ketoprostaglandin delta 13-reductase activity in bovine ocular tissues |
Bos taurus |
1.3.1.48 | 15-Ketoprostaglandin delta13 reductase from human placenta: purification, kinetics, and inhibitor binding |
Homo sapiens |
1.3.1.48 | Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase |
Rattus norvegicus |
1.3.1.48 | Crystal structure of anti-configuration of indomethacin and leukotriene B4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase complex reveals the structural basis of broad spectrum indomethacin efficacy |
Cavia porcellus |
1.3.1.48 | Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation |
Mus musculus |
1.3.1.48 | Immunohistochemical localization of guinea-pig leukotriene B4 12-hydroxydehydrogenase/15-ketoprostaglandin 13-reductase |
Cavia porcellus |
1.3.1.48 | Isolation and properties of a 15-ketoprostaglandin delta 13-reductase from human placenta |
Homo sapiens |
1.3.1.48 | Leukotriene B4 12-hydroxydehydrogenase/15-ketoprostaglandin DELTA13-reductase (LTB4 12-HD/PGR) responsible for the reduction of a double-bond of the alpha,beta-unsaturated ketone of an aryl propionic acid non-steroidal anti-inflammatory agent CS-670 |
Rattus norvegicus |